Clinicopathological value of somatostatin type 2A and estrogen receptor immunoreactivity in human breast carcinoma

Endocrine Pathology

Volumn 12, Issue 1, 2001, Pages 55-61

  Pilichowska, M ^a   Kimura, N ^a   Suzuki, A ^a   Yoshida, R ^a   Schindler, M ^a   Nagura, H ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast carcinoma; Histological grade; Immunohistochemistry; Prognostic index; Receptor; Somatostatin

Indexed keywords

ESTROGEN RECEPTOR; SOMATOSTATIN;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, SOMATOSTATIN;

EID: 0034971047     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:12:1:55     Document Type: Article

References (38)

1. Steroid hormone receptors in breast cancer management
2. The role of somatostatin and its analogs in the diagnosis and treatment of tumors
3. Octreotide
4. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
5. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion
6. Oncological applications of somatostatin analogues
7. Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and sandostatin
8. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7, 12-dimethylbenz antracene-induced rat mammary carcinomas
9. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and a kidney
10. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase
11. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype
12. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2
13. Analysis of somatostatin receptor subtype mRNA expression in human breast cancer
14. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: Comparison of mRNA analysis with receptor autoradiography
15. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma
16. Expression of somatostatin type 2A receptor correlates with estrogen receptor in human breast carcinoma
17. Confirmation of a prognostic index in primary breast cancer
18. Pathological prognostic factors in breast cancer. I The value of histological grade in breast cancer: Experience from a large study with long-term follow up
19. Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord
20. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling
21. Somatostatin and its receptor family
22. Receptors of dopamine and somatostatin: Formation of heterooligomers with enhanced functional activity
23. Comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients
24. Somatostatin-14 mainly binds the somatostatin receptor subtype 2 in human neuroblastoma tumors
25. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer
26. Immunohistochemical localisation of somatostatin receptors sst2A in human tumors
27. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization
28. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells
29. 17-Beta-estradiol-dependent regulation of somatostatin receptor subtype expression in the 7315b prolactin secreting rat pituitary tumor in vitro and in vivo
30. Histological grading and prognosis in breast cancer
31. Correlation of primary breast cancer histopathology and estrogen receptor content
32. Relationship between oestrogen-receptor content and histological grade in human primary breast tumours
33. Correlation of hormone receptors with pathological features in human breast cancer
34. Definition, reproductibilite du grading de Scarff et Bloom
35. Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer
36. Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer
37. Effect of the long-acting somatostatin analogue SMS 201-995 (Sandostatin) in advanced breast cancer